Partial Motor Epilepsy with "Negative Myoclonus"

Three children had both nocturnal unilateral motor seizures and daytime ipsilateral "negative myoclonus" which occurred so frequently that it resembled asterixis. Neurophysiologic studies demonstrated lateralized spike discharges that were time-locked to postural lapse in the contralateral outstretched arm. The clinical course was characterized by good seizure control with benzodiazepines.     

Generation and propagation of 4-AP-induced epileptiform activity in neonatal intact limbic structures in vitro

We examined the generation, propagation and pharmacology of 4-aminopyridine (4-AP)-induced epileptiform activity (EA) in the intact interconnected limbic structure of the newborn (P0-7) rat in vitro. Whole-cell recordings of CA3 pyramidal cells and multisite field potential recordings in CA3, CA1, dentate gyrus, and lateral and medial entorhinal cortex revealed 4-AP-induced EA as early as P0-1. At this age, EA was initiated in the CA3 region and propagated to CA1, but not to the entorhinal cortex. Starting from P3-4, EA propagated from CA3 to the entorhinal cortex. Along the CA3 septo-temporal axis, EA arose predominantly from the septal pole and spread towards the temporal site. Whereas the onset of 4-AP-induced EA decreased with age from 21.2 +/- 1.6 min at P0-1 to 4.7 +/- 0.63 min at P6-7, the seizure duration increased in the same age groups from 98 +/- 14 s to 269.4 +/- 85.9 s, respectively. The EA was blocked by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) but not by DL-2-amino-5-phosphonovaleric acid (APV), (+)-MK-801 hydrogen maleate (MK-801) or (+/-)-alpha-methyl-4-carboxyphenylglycine (MCPG), suggesting that they were mediated by alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA)/kainate receptor activation. We conclude that: (i) the septal pole of the hippocampal CA3 region plays a central role in the generation of EA in the neonatal limbic system; and (ii) AMPA/kainate receptor-mediated EA can be generated in CA3 already at birth. Therefore, the recurrent collateral synapses and circuits required for the generation of EA are developed earlier than previously suggested on the basis of studies on hippocampal slices.     

In vivo and in vitro effects of melatonin or ganglioside GT1B on L-cysteine-induced brain mitochondrial DNA damage in mice.

The effects of L-cysteine on mitochondrial DNA (mtDNA) in mouse brain were investigated both in vivoandin vitro. An intracerebroventricular (icv) injection of L-cysteine (1.25 micromol/animal) caused mtDNA damage in brain frontal and central portions of the cortex, broad-spectrum limbic and severe sustained seizures in mice, and increased lipid peroxidation in the whole brain. The L-cysteine-mediated effects were prevented by an intraperitoneal (ip) preinjection of melatonin (20 mg/kg) or an intracerebroventricular preinjection of ganglioside GT1b (90 nmol/animal). Furthermore, in in vitroexperiments, L-cysteine (0.05, 0.5, or 1.0 mM) caused damage to brain mtDNA and increased lipid peroxidation in a concentration-dependent manner when incubated at 37 degrees C for 20 or 60 min with a homogenate prepared from whole mouse brains. However, the mtDNA damage and the increased lipid peroxidation were completely abolished by a cotreatment with melatonin (1.5 mM), a potent scavenger of the hydroxyl radical (*OH), or ganglioside GT1b (60 microM), a potent inhibitor of glutamate-receptor-mediated activation and translocation of protein kinase C and lipid peroxidation. These results suggest that reactive oxygen species including the *OH may be involved in l-cysteine-induced brain mtDNA damage, lipid peroxidation, and development of seizures in mice. Therefore, we concluded that *OH scavengers, such as the pineal hormone melatonin and ganglioside GT1b, can protect against brain mtDNA damage, seizures, and lipid peroxidation induced by reactive oxygen species producers such as L-cysteine.     

Proteus syndrome

Abstract: This female Asian (Malay) baby had clinical features of Proteus syndrome. She had a large right facial lipolymphangioma with hyperpigmentation of the overlying skin. There was a smaller lymphangioma over the left side of her neck with excess nuchal folds, macrodactyly and bilateral talipes equinovarus. Despite the extensive hemifacial swelling, there was no evidence of upper respiratory tract obstruction. Generalized seizures developed on the sixth day of life which were controlled with phenobarbital. The lymphangiomas were excised without recurrence.     

热性惊厥对大鼠情感行为及学习记忆的影响

【目的】　探讨热性惊厥对大鼠情感行为及学习记忆能力的影响。　【方法】　 3 6只雄性SD (Spraque Dawley)大鼠随机分为热性惊厥组 (febrileseizuresgroup ,FS) ,发热对照组 (febrilecontrolgroup ,FG)及正常对照组 (nor malcontrolgroup ,NG)。观察各组大鼠在旷场试验 (openfieldtest ,OFT)、避暗试验 (passiveavoidancetest,PAT)以及在Morris水迷宫 (Morriswatermaze ,MWM )试验中情感行为及学习记忆能力的改变。　【结果】　FS组大鼠与NG、FG组相比 :在OFT中穿格得分分值 ( 3 7.48± 7.0 9)降低 ,后肢性站立的次数 ( 12 .11± 4.41)减少 ,排出粪便粒数 ( 10 .62±2 .3 2 )增多 ,差异有非常显著性 (P <0 .0 1) ;在PAT中 ,FS组大鼠犯错次数 ( 4 .0 2± 1.2 9)增加 ,且记忆潜伏期 [( 169.71± 10 3 .2 2 )秒 ]缩短 ,差异有非常显著性 (P <0 .0 1) ;在Morris水迷宫试验中 ,FS组大鼠搜寻站台的逃逸潜伏期明显延长 ,差异有非常显著性 (P <0 .0 1)。　【结论】　多次热性惊厥发作可使大鼠的情感行为和学习记忆能力受损     

卡马西平和托吡酯联合治疗复杂部分性癫痫29例

目的观察卡马西平和托吡酯联合治疗复杂部分性癫痫的临床疗效及安全性.方法对29例患儿在单用卡马西平治疗的基础上,加用托吡酯联合治疗.结果加用托吡酯后疗效明显,总有效率达69%,发作完全控制率占38%.结论研究结果表明,两药联合治疗复杂部分性癫痫是安全有效的.     

针刺对备用根猫背根节神经元IGF-Ⅰ表达的影响

目的观察胰岛素样生长因子-I（IGF—I）在正常猫、部分去背根猫及针刺部分去背根猫的L6手术侧背根节（DRG）表达的时空变化，以了解IGF—I与针刺促进脊髓可塑性的关系。方法25只成年健康雄猫随机分为5组：即正常组、备用根术后7d组与14d组（动物行单侧部分去背根手术，即切除一侧L1～L5、L7～S2背根节，保留L6为备用根）、针刺备用根术后7d组与14d组（动物行单侧部分去背根术后针刺L6脊神经外周支配区内的两组穴位）。动物于术后7d、14d分别处死，取各组（手术侧）L。背根节，-20℃恒冷箱切片，片厚20μm，用兔抗IGF—I（1：200）抗体行免疫组化ABC法染色。观察、计数并比较各组背根节IGF—I阳性神经元的分布、含量及时空变化。结果针刺备用根7d组，DRGIGF—I阳性神经元数较术后7d组明显增加（P〈0．05），但仍低于正常水平；针刺14d，DRG阳性神经元比术后14d亦增多（P〈0．01），且恢复至正常水平。与针刺7d组比较，DRGIGF—I阳性神经元在针刺14d时明显增多（P〈0．05）。结论针刺可增加针刺侧DRG内IGF—I阳性中小神经元数。提示针刺后IGF—I在背根节的表达变化可能与针刺促进脊髓可塑性有关。     

TURBT术治疗T1T2期膀胱癌91例

目的:分析两种手术方法对T1T2期膀胱癌的治疗效果。方法:根据病史、体格检查、B超、3D-CT、膀胱镜活组织检查确诊的T1T2期膀胱癌152例,采用TURBT术(经尿道膀胱肿瘤切除术)91例,膀胱局部切除术61例,分析比较治疗效果。结果:两种手术方法疗效无显著特异性,患者生存率与肿瘤病理分期有直接相关性。结论:T1T2期膀胱癌采用TURBT术与采用膀胱局部切除术疗效相当,但TURBT费用低,创伤少,便于再次手术,有推广意义。     

柴贝止痫汤添加治疗难治性癫痫复杂部分性发作的临床研究

目的观察评价刘金民教授治疗难治性癫痫经验用方柴贝止痫汤联合抗癫痫药物(anti-epileptic drugs,AEDs)治疗难治性癫痫复杂部分性发作的临床疗效和安全性。方法选择符合诊断和纳入标准的病例60例,随机分为治疗组和对照组,分别给予AEDs添加柴贝止痫汤及单纯的AEDs治疗。定期随诊并记录治疗后患者的痫性发作频率、中医症状积分及不良反应等。以痫性发作频率、中医症状积分及脑电图异常程度的改善程度作为疗效判定标准。结果在改善患者的痫性发作频率方面,经Wilcoxon秩和检验,治疗12周后,治疗组疗效优于对照组(P0.05);经χ2检验,治疗8周、12周后,治疗组疗效优于对照组(P0.05)。在改善患者的中医症状积分方面,经Repested Measures检验(Greenhouse-Geisser法校正),治疗4周、8周、12周的不同观测时点、观测时点与组别的交互作用及组别之间的差异均具有统计学意义(P0.05);经χ2检验,治疗8周、12周后,治疗组疗效优于对照组(P0.05);经秩和检验,治疗4周后,在失眠症状积分上,治疗组疗效优于对照组(P0.05),治疗8周、12周后,在胸闷、痰多、疲乏、失眠四个症状积分上,治疗组疗效优于对照组(P0.05)。结论柴贝止痫汤添加用药治疗难治性癫痫复杂部分性发作,在改善患者的痫性发作频率及中医症状积分上均有明显的优势,且随着疗程的延长,疗效逐渐显著,未发现任何不良反应。柴贝止痫汤添加治疗难治性癫痫复杂部分性发作安全、有效。